[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dermatophytic Onychomycosis Market Growth (Status and Outlook) 2024-2030

May 2024 | 116 pages | ID: GC54A6557227EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.

The global Dermatophytic Onychomycosis market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Dermatophytic Onychomycosis Industry Forecast” looks at past sales and reviews total world Dermatophytic Onychomycosis sales in 2023, providing a comprehensive analysis by region and market sector of projected Dermatophytic Onychomycosis sales for 2024 through 2030. With Dermatophytic Onychomycosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dermatophytic Onychomycosis industry.

This Insight Report provides a comprehensive analysis of the global Dermatophytic Onychomycosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dermatophytic Onychomycosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dermatophytic Onychomycosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dermatophytic Onychomycosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dermatophytic Onychomycosis.

Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatophytic Onychomycosis market by product type, application, key players and key regions and countries.

Segmentation by type
  • Oral Medicine
  • External Medicine
Segmentation by application
  • Age Under 18
  • Age 18-50
  • Age Above 50
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Johnson & Johnson
  • GSK
  • Novartis
  • Pfizer
  • Bausch Health
  • Kaken Pharmaceutical
  • Galderma
  • Sanofi
  • Allergan
  • Merz Pharma
  • Xiuzheng Pharmaceutical
  • Letai
  • Qilu Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dermatophytic Onychomycosis Market Size 2019-2030
  2.1.2 Dermatophytic Onychomycosis Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Dermatophytic Onychomycosis Segment by Type
  2.2.1 Oral Medicine
  2.2.2 External Medicine
2.3 Dermatophytic Onychomycosis Market Size by Type
  2.3.1 Dermatophytic Onychomycosis Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
2.4 Dermatophytic Onychomycosis Segment by Application
  2.4.1 Age Under
  2.4.2 Age 18-50
  2.4.3 Age Above
2.5 Dermatophytic Onychomycosis Market Size by Application
  2.5.1 Dermatophytic Onychomycosis Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)

3 DERMATOPHYTIC ONYCHOMYCOSIS MARKET SIZE BY PLAYER

3.1 Dermatophytic Onychomycosis Market Size Market Share by Players
  3.1.1 Global Dermatophytic Onychomycosis Revenue by Players (2019-2024)
  3.1.2 Global Dermatophytic Onychomycosis Revenue Market Share by Players (2019-2024)
3.2 Global Dermatophytic Onychomycosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DERMATOPHYTIC ONYCHOMYCOSIS BY REGIONS

4.1 Dermatophytic Onychomycosis Market Size by Regions (2019-2024)
4.2 Americas Dermatophytic Onychomycosis Market Size Growth (2019-2024)
4.3 APAC Dermatophytic Onychomycosis Market Size Growth (2019-2024)
4.4 Europe Dermatophytic Onychomycosis Market Size Growth (2019-2024)
4.5 Middle East & Africa Dermatophytic Onychomycosis Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Dermatophytic Onychomycosis Market Size by Country (2019-2024)
5.2 Americas Dermatophytic Onychomycosis Market Size by Type (2019-2024)
5.3 Americas Dermatophytic Onychomycosis Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dermatophytic Onychomycosis Market Size by Region (2019-2024)
6.2 APAC Dermatophytic Onychomycosis Market Size by Type (2019-2024)
6.3 APAC Dermatophytic Onychomycosis Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Dermatophytic Onychomycosis by Country (2019-2024)
7.2 Europe Dermatophytic Onychomycosis Market Size by Type (2019-2024)
7.3 Europe Dermatophytic Onychomycosis Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dermatophytic Onychomycosis by Region (2019-2024)
8.2 Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2019-2024)
8.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS MARKET FORECAST

10.1 Global Dermatophytic Onychomycosis Forecast by Regions (2025-2030)
  10.1.1 Global Dermatophytic Onychomycosis Forecast by Regions (2025-2030)
  10.1.2 Americas Dermatophytic Onychomycosis Forecast
  10.1.3 APAC Dermatophytic Onychomycosis Forecast
  10.1.4 Europe Dermatophytic Onychomycosis Forecast
  10.1.5 Middle East & Africa Dermatophytic Onychomycosis Forecast
10.2 Americas Dermatophytic Onychomycosis Forecast by Country (2025-2030)
  10.2.1 United States Dermatophytic Onychomycosis Market Forecast
  10.2.2 Canada Dermatophytic Onychomycosis Market Forecast
  10.2.3 Mexico Dermatophytic Onychomycosis Market Forecast
  10.2.4 Brazil Dermatophytic Onychomycosis Market Forecast
10.3 APAC Dermatophytic Onychomycosis Forecast by Region (2025-2030)
  10.3.1 China Dermatophytic Onychomycosis Market Forecast
  10.3.2 Japan Dermatophytic Onychomycosis Market Forecast
  10.3.3 Korea Dermatophytic Onychomycosis Market Forecast
  10.3.4 Southeast Asia Dermatophytic Onychomycosis Market Forecast
  10.3.5 India Dermatophytic Onychomycosis Market Forecast
  10.3.6 Australia Dermatophytic Onychomycosis Market Forecast
10.4 Europe Dermatophytic Onychomycosis Forecast by Country (2025-2030)
  10.4.1 Germany Dermatophytic Onychomycosis Market Forecast
  10.4.2 France Dermatophytic Onychomycosis Market Forecast
  10.4.3 UK Dermatophytic Onychomycosis Market Forecast
  10.4.4 Italy Dermatophytic Onychomycosis Market Forecast
  10.4.5 Russia Dermatophytic Onychomycosis Market Forecast
10.5 Middle East & Africa Dermatophytic Onychomycosis Forecast by Region (2025-2030)
  10.5.1 Egypt Dermatophytic Onychomycosis Market Forecast
  10.5.2 South Africa Dermatophytic Onychomycosis Market Forecast
  10.5.3 Israel Dermatophytic Onychomycosis Market Forecast
  10.5.4 Turkey Dermatophytic Onychomycosis Market Forecast
  10.5.5 GCC Countries Dermatophytic Onychomycosis Market Forecast
10.6 Global Dermatophytic Onychomycosis Forecast by Type (2025-2030)
10.7 Global Dermatophytic Onychomycosis Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Johnson & Johnson
  11.1.1 Johnson & Johnson Company Information
  11.1.2 Johnson & Johnson Dermatophytic Onychomycosis Product Offered
  11.1.3 Johnson & Johnson Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Johnson & Johnson Main Business Overview
  11.1.5 Johnson & Johnson Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK Dermatophytic Onychomycosis Product Offered
  11.2.3 GSK Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Novartis
  11.3.1 Novartis Company Information
  11.3.2 Novartis Dermatophytic Onychomycosis Product Offered
  11.3.3 Novartis Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Novartis Main Business Overview
  11.3.5 Novartis Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Dermatophytic Onychomycosis Product Offered
  11.4.3 Pfizer Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Bausch Health
  11.5.1 Bausch Health Company Information
  11.5.2 Bausch Health Dermatophytic Onychomycosis Product Offered
  11.5.3 Bausch Health Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Bausch Health Main Business Overview
  11.5.5 Bausch Health Latest Developments
11.6 Kaken Pharmaceutical
  11.6.1 Kaken Pharmaceutical Company Information
  11.6.2 Kaken Pharmaceutical Dermatophytic Onychomycosis Product Offered
  11.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Kaken Pharmaceutical Main Business Overview
  11.6.5 Kaken Pharmaceutical Latest Developments
11.7 Galderma
  11.7.1 Galderma Company Information
  11.7.2 Galderma Dermatophytic Onychomycosis Product Offered
  11.7.3 Galderma Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Galderma Main Business Overview
  11.7.5 Galderma Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Dermatophytic Onychomycosis Product Offered
  11.8.3 Sanofi Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments
11.9 Allergan
  11.9.1 Allergan Company Information
  11.9.2 Allergan Dermatophytic Onychomycosis Product Offered
  11.9.3 Allergan Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Allergan Main Business Overview
  11.9.5 Allergan Latest Developments
11.10 Merz Pharma
  11.10.1 Merz Pharma Company Information
  11.10.2 Merz Pharma Dermatophytic Onychomycosis Product Offered
  11.10.3 Merz Pharma Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Merz Pharma Main Business Overview
  11.10.5 Merz Pharma Latest Developments
11.11 Xiuzheng Pharmaceutical
  11.11.1 Xiuzheng Pharmaceutical Company Information
  11.11.2 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product Offered
  11.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Xiuzheng Pharmaceutical Main Business Overview
  11.11.5 Xiuzheng Pharmaceutical Latest Developments
11.12 Letai
  11.12.1 Letai Company Information
  11.12.2 Letai Dermatophytic Onychomycosis Product Offered
  11.12.3 Letai Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Letai Main Business Overview
  11.12.5 Letai Latest Developments
11.13 Qilu Pharmaceutical
  11.13.1 Qilu Pharmaceutical Company Information
  11.13.2 Qilu Pharmaceutical Dermatophytic Onychomycosis Product Offered
  11.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Qilu Pharmaceutical Main Business Overview
  11.13.5 Qilu Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Dermatophytic Onychomycosis Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral Medicine
Table 3. Major Players of External Medicine
Table 4. Dermatophytic Onychomycosis Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Dermatophytic Onychomycosis Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Table 7. Dermatophytic Onychomycosis Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Dermatophytic Onychomycosis Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Table 10. Global Dermatophytic Onychomycosis Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Dermatophytic Onychomycosis Revenue Market Share by Player (2019-2024)
Table 12. Dermatophytic Onychomycosis Key Players Head office and Products Offered
Table 13. Dermatophytic Onychomycosis Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Dermatophytic Onychomycosis Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Dermatophytic Onychomycosis Market Size Market Share by Regions (2019-2024)
Table 18. Global Dermatophytic Onychomycosis Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Dermatophytic Onychomycosis Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Dermatophytic Onychomycosis Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Dermatophytic Onychomycosis Market Size Market Share by Country (2019-2024)
Table 22. Americas Dermatophytic Onychomycosis Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Table 24. Americas Dermatophytic Onychomycosis Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Table 26. APAC Dermatophytic Onychomycosis Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Dermatophytic Onychomycosis Market Size Market Share by Region (2019-2024)
Table 28. APAC Dermatophytic Onychomycosis Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Table 30. APAC Dermatophytic Onychomycosis Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Table 32. Europe Dermatophytic Onychomycosis Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Dermatophytic Onychomycosis Market Size Market Share by Country (2019-2024)
Table 34. Europe Dermatophytic Onychomycosis Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Table 36. Europe Dermatophytic Onychomycosis Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Dermatophytic Onychomycosis Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Dermatophytic Onychomycosis Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Dermatophytic Onychomycosis Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Dermatophytic Onychomycosis Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Dermatophytic Onychomycosis
Table 45. Key Market Challenges & Risks of Dermatophytic Onychomycosis
Table 46. Key Industry Trends of Dermatophytic Onychomycosis
Table 47. Global Dermatophytic Onychomycosis Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Dermatophytic Onychomycosis Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Dermatophytic Onychomycosis Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Dermatophytic Onychomycosis Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Johnson & Johnson Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 52. Johnson & Johnson Dermatophytic Onychomycosis Product Offered
Table 53. Johnson & Johnson Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. GSK Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 57. GSK Dermatophytic Onychomycosis Product Offered
Table 58. GSK Main Business
Table 59. GSK Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GSK Latest Developments
Table 61. Novartis Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 62. Novartis Dermatophytic Onychomycosis Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Pfizer Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 67. Pfizer Dermatophytic Onychomycosis Product Offered
Table 68. Pfizer Main Business
Table 69. Pfizer Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Pfizer Latest Developments
Table 71. Bausch Health Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 72. Bausch Health Dermatophytic Onychomycosis Product Offered
Table 73. Bausch Health Main Business
Table 74. Bausch Health Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bausch Health Latest Developments
Table 76. Kaken Pharmaceutical Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 77. Kaken Pharmaceutical Dermatophytic Onychomycosis Product Offered
Table 78. Kaken Pharmaceutical Main Business
Table 79. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Kaken Pharmaceutical Latest Developments
Table 81. Galderma Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 82. Galderma Dermatophytic Onychomycosis Product Offered
Table 83. Galderma Main Business
Table 84. Galderma Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Galderma Latest Developments
Table 86. Sanofi Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 87. Sanofi Dermatophytic Onychomycosis Product Offered
Table 88. Sanofi Main Business
Table 89. Sanofi Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Sanofi Latest Developments
Table 91. Allergan Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 92. Allergan Dermatophytic Onychomycosis Product Offered
Table 93. Allergan Main Business
Table 94. Allergan Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Allergan Latest Developments
Table 96. Merz Pharma Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 97. Merz Pharma Dermatophytic Onychomycosis Product Offered
Table 98. Merz Pharma Main Business
Table 99. Merz Pharma Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Merz Pharma Latest Developments
Table 101. Xiuzheng Pharmaceutical Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 102. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product Offered
Table 103. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Xiuzheng Pharmaceutical Main Business
Table 105. Xiuzheng Pharmaceutical Latest Developments
Table 106. Letai Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 107. Letai Dermatophytic Onychomycosis Product Offered
Table 108. Letai Main Business
Table 109. Letai Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Letai Latest Developments
Table 111. Qilu Pharmaceutical Details, Company Type, Dermatophytic Onychomycosis Area Served and Its Competitors
Table 112. Qilu Pharmaceutical Dermatophytic Onychomycosis Product Offered
Table 113. Qilu Pharmaceutical Main Business
Table 114. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Qilu Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Dermatophytic Onychomycosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dermatophytic Onychomycosis Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Dermatophytic Onychomycosis Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Dermatophytic Onychomycosis Sales Market Share by Country/Region (2023)
Figure 8. Dermatophytic Onychomycosis Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Dermatophytic Onychomycosis Market Size Market Share by Type in 2023
Figure 10. Dermatophytic Onychomycosis in Age Under 18
Figure 11. Global Dermatophytic Onychomycosis Market: Age Under 18 (2019-2024) & ($ Millions)
Figure 12. Dermatophytic Onychomycosis in Age 18-50
Figure 13. Global Dermatophytic Onychomycosis Market: Age 18-50 (2019-2024) & ($ Millions)
Figure 14. Dermatophytic Onychomycosis in Age Above 50
Figure 15. Global Dermatophytic Onychomycosis Market: Age Above 50 (2019-2024) & ($ Millions)
Figure 16. Global Dermatophytic Onychomycosis Market Size Market Share by Application in 2023
Figure 17. Global Dermatophytic Onychomycosis Revenue Market Share by Player in 2023
Figure 18. Global Dermatophytic Onychomycosis Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Dermatophytic Onychomycosis Market Size 2019-2024 ($ Millions)
Figure 20. APAC Dermatophytic Onychomycosis Market Size 2019-2024 ($ Millions)
Figure 21. Europe Dermatophytic Onychomycosis Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Dermatophytic Onychomycosis Market Size 2019-2024 ($ Millions)
Figure 23. Americas Dermatophytic Onychomycosis Value Market Share by Country in 2023
Figure 24. United States Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Dermatophytic Onychomycosis Market Size Market Share by Region in 2023
Figure 29. APAC Dermatophytic Onychomycosis Market Size Market Share by Type in 2023
Figure 30. APAC Dermatophytic Onychomycosis Market Size Market Share by Application in 2023
Figure 31. China Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Dermatophytic Onychomycosis Market Size Market Share by Country in 2023
Figure 38. Europe Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Figure 39. Europe Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Figure 40. Germany Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Dermatophytic Onychomycosis Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Dermatophytic Onychomycosis Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Dermatophytic Onychomycosis Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Dermatophytic Onychomycosis Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 54. APAC Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 55. Europe Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 57. United States Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 58. Canada Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 61. China Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 62. Japan Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 63. Korea Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 65. India Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 66. Australia Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 67. Germany Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 68. France Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 69. UK Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 70. Italy Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 71. Russia Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 72. Spain Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 75. Israel Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Dermatophytic Onychomycosis Market Size 2025-2030 ($ Millions)
Figure 78. Global Dermatophytic Onychomycosis Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Dermatophytic Onychomycosis Market Size Market Share Forecast by Application (2025-2030)


More Publications